Formulation and Drug Delivery

Innovative Start-Ups at CPHI Barcelona

October 15, 2023

The Start-Up Market at CPHI Barcelona will bring together 27 start-ups, innovators, and small enterprises from across the pharma landscape.

Trends in Formulation for Highly Potent Drugs

October 15, 2023

When considering manufacturing and the growth of drug formulation, it is evident that there has been change and many new advancements introduced to make processes more efficient.

Welcome to CPHI Barcelona

October 15, 2023

Sherma Ellis Daal, brand director, Pharma at Informa Markets, gives a preview of CPHI Barcelona 2023.

The Impact of AI on Pharma

October 15, 2023

CPHI’s Annual Report predicts huge impact of AI on drug development and manufacturing.

GSK and Zhifei Partner to Extend the Availability of Shingrix

October 12, 2023

The companies will co-promote GSK’s shingles vaccine, Shingrix, to healthcare professionals and points of vaccination in China.

FDA Issues Guidance for Topical Ophthalmic Drugs

October 12, 2023

The draft guidance document discusses quality considerations for topical ophthalmic drug products.

Lilly to Acquire POINT Biopharma

October 05, 2023

POINT is a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies in development for the treatment of cancer.

Pfizer and Ginkgo Bioworks to Collaborate on Multi-Target RNA Discovery

October 04, 2023

Pfizer has entered into a collaboration with Ginkgo Bioworks to discover novel RNA molecules across priority research areas.

Driving Dosage Form Developments

September 29, 2023

Dosage forms are being shaped by numerous factors, with patient-centricity continuing to be an important driver of decisions in development.

EC Approves Polpharma Biologics’ MS-Treating Biosimilar

September 28, 2023

The European Commission has granted approval for Tyruko (natalizumab), a biosimilar developed by Polpharma Biologics for treating multiple sclerosis.